Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    Contact Supplier

    Menu

    Naproxen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Artelo's ART26.12 Compares to Naproxen in Osteoarthritis Study
    Artelo's ART26.12 Compares to Naproxen in Osteoarthritis Study

    05 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/05/3094403/0/en/Artelo-s-Fatty-Acid-Binding-Protein-5-Inhibitor-ART26-12-Compares-Favorably-to-Naproxen-in-an-Osteoarthritis-Pain-Study.html

    GLOBENEWSWIRE
    05 Jun 2025
    Share Share
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907285/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Naproxen-Delayed-Release-Tablets-USP.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Novitium Pharma's Generic Naproxen Receives Approval in US
    Novitium Pharma's Generic Naproxen Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218497

    FDA
    12 Jun 2024
    Share Share
    Enforcement Report - Week of December 6, 2023
    Enforcement Report - Week of December 6, 2023

    06 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2023-46648.pdf

    FDA
    06 Dec 2023
    Share Share
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.

    24 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204470

    FDA
    24 Aug 2022
    Share Share
    Hetero lab III's Generic Naproxen Receives Apprival in the U.S
    Hetero lab III's Generic Naproxen Receives Apprival in the U.S

    07 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215776

    FDA
    07 Jun 2022
    Share Share